Discovery of FIXa inhibitors by combination of pharmacophore modeling, molecular docking, and 3D-QSAR modeling
- 4 May 2018
- journal article
- research article
- Published by Taylor & Francis in Journal of Receptors and Signal Transduction
- Vol. 38 (3) , 213-224
Abstract
Human Coagulation Factor IXa (FIXa), specifically inhibited at the initiation stage of the blood coagulation cascade, is an excellent target for developing selective and safe anticoagulants. To explore this inhibitory mechanism, 86 FIXa inhibitors were selected to generate pharmacophore models and subsequently SAR models. Both best pharmacophore model and ROC curve were built through the Receptor–Ligand Pharmacophore Generation module. CoMFA model based on molecular docking and PLS factor analysis methods were developed. Model propagations values are q2 = 0.709, r2 = 0.949, and r2pred = 0.905. The satisfactory q2 value of 0.609, r2 value of 0.962, and r2pred value of 0.819 for CoMSIA indicated that the CoMFA and CoMSIA models are both available to predict the inhibitory activity on FIXa. On the basis of pharmacophore modeling, molecular docking, and 3D-QSAR modeling screening, six molecules are screened as potential FIXa inhibitors.Keywords
Funding Information
- Chinese Academy of Sciences (XDA12030206)
- National Natural Science Foundation of China (21772207)
This publication has 32 references indexed in Scilit:
- Protein–Ligand-Based Pharmacophores: Generation and Utility Assessment in Computational Ligand ProfilingJournal of Chemical Information and Modeling, 2012
- Modeling of Human Prokineticin Receptors: Interactions with Novel Small-Molecule Binders and Potential Off-Target DrugsPLOS ONE, 2011
- Investigation on the binding mode of benzothiophene analogues as potent factor IXa (FIXa) inhibitors in thrombosis by CoMFA, docking and molecular dynamic studiesJournal of Enzyme Inhibition and Medicinal Chemistry, 2011
- New parenteral anticoagulants in developmentTherapeutic Advances in Cardiovascular Disease, 2010
- Studies of Benzothiophene Template as Potent Factor IXa (FIXa) Inhibitors in ThrombosisJournal of Medicinal Chemistry, 2010
- Consensus Superiority of the Pharmacophore-Based Alignment, Over Maximum Common Substructure (MCS): 3D-QSAR Studies on Carbamates as Acetylcholinesterase InhibitorsJournal of Chemical Information and Modeling, 2009
- Low molecular weight heparin and bleeding in patients with chronic renal failureCurrent Opinion in Pulmonary Medicine, 2007
- Factor IXa Inhibitors as Novel AnticoagulantsArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- New anticoagulantsBlood, 2005
- Molecular Similarity Indices in a Comparative Analysis (CoMSIA) of Drug Molecules to Correlate and Predict Their Biological ActivityJournal of Medicinal Chemistry, 1994